The regulation of complementary and alternative medicines in South Africa has been hotly contested in recent decades, including in court rooms. In his latest column for Spotlight, Dr Andy Gray unpacks the legal background and the current state of this still unfolding regulatory saga.
High-octane executive force Marlene le Roux tells Biénne Huisman about contracting polio when she was three months old, about not dimming her light, and renovations that made the Artscape Theatre Centre in Cape Town one of South Africa’s most accessible public spaces.
From inspecting spaza shops to monitoring water quality, Environmental Health Practitioners help prevent disease before outbreaks occur. A Public Protector investigation reveals why Gauteng municipalities are struggling to deliver these essential public health services. The investigation also helps clarify what will be at stake in South Africa’s local government elections in November. Christina Pitt reports.
Dr Hermann Reuter did pioneering work treating HIV in the early 2000s in Cape Town and in the rural Eastern Cape. Today, his focus is substance abuse, which he believes is the country’s biggest health issue after HIV. Sue Segar spent time with him to learn about his work in the Garden Route city of George.
With plans in motion to roll out universal health coverage in South Africa, Dr Katlego Mothudi, of the Board of Healthcare Funders, argues that revising the compulsory prescribed minimum benefits that medical schemes must provide can be a tool to deliver meaningful improvements today while laying the foundations for a more sustainable healthcare system tomorrow.
South Africa has an ageing population of people living with HIV. For the first time a set of clinical guidelines maps out a framework to help keep this group of people healthier for longer, reports Elna Schütz.
If an HIV prevention pill that provides a month of protection at a time performs well in two ongoing clinical trials, it could become the next big thing in HIV prevention after the lenacapavir injection. A new licensing agreement is paving the way for South Africa’s Aspen Pharmacare to produce the pill should the study findings be positive and the drug be registered.
A new antiretroviral combination pill that is taken only once a week appears to work as well as daily pills at treating HIV. This is according to interim study findings to be presented next week at the AIDS 2026 conference in Rio de Janeiro, Brazil.
A high-profile court case has thrust the legalities of compounding medicines in South Africa into the spotlight. Behind the immediate legal issues, hide a series of unresolved questions about how we should ensure that compounded medicines used in South Africa are safe, argue Professor Renier Coetzee and Lara van Niekerk.
An NGO offers safe, private HIV services to Men who Have Sex with Men and transgender people in George. Sue Segar met with some of the people using these services, and found the NGO, TB HIV Care are already providing relief from the hostile reactions trans people sometimes experience in government clinics.
Dr Andrew Ross’s idea of sponsoring rural students to study for careers in healthcare has succeeded beyond his dreams. Sue Segar sat down with him and chatted to the four students who bagged the initial fully funded scholarships and who went on to land senior roles in public health.
Being a researcher who studies tuberculosis in the lab is one thing, having the TB bug in your lungs is quite another. Elri Voigt sat down with two of a relatively small number of people who have experienced both.
